Thomas Wilder

Thomas Wilder

Director/Board Member at PENUMBRA, INC.

Net worth: 2 M $ as of 31/08/2026

62 year
Health Technology
Consumer Services
Finance

Profile

Mr. Thomas C.
Wilder
is a Chief Executive Officer at VS3 Medical, Inc., an Advisor at Vensana Capital Management LLC, an Independent Director at Penumbra, Inc. and an Independent Director at Neuros Medical, Inc. He is on the Board of Directors at Penumbra, Inc. and Neuros Medical, Inc. Mr. Wilder was previously employed as a Senior Advisor by CBC Group (Singapore) Pte.
Ltd., an Independent Director by Endologix LLC, a President, Chief Executive Officer & Director by Sequent Medical, Inc., a President & Chief Executive Officer by PhotoThera, Inc., a President & Chief Executive Officer by Micro Therapeutics, Inc., a VP & GM-Endovascular Stent Grafts Division by Medtronic, Inc., a President by ev3, Inc., and a Vice President-Finance & Information Technology by Medtronic Vascular, Inc. He also served on the board at Benvenue Medical, Inc. He received his undergraduate degree from Stanford University and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 4,653 ( 0.01% ) 2 M $ 31/08/2026

Thomas Wilder active positions

CompaniesPositionStart
PENUMBRA, INC. Director/Board Member 13/01/2017
Director/Board Member 28/08/2017
Consultant / Advisor 01/10/2019
Chief Executive Officer 01/06/2024

Former positions of Thomas Wilder

CompaniesPositionEnd
ENDOLOGIX, INC. Director/Board Member 01/10/2020
Director/Board Member 01/04/2017
Chief Executive Officer 01/07/2016
Chief Executive Officer 30/04/2009
President -
See the detail of Thomas Wilder's experience

Training of Thomas Wilder

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Finance

Health Services